Biosig Technologies Inc
NASDAQ:BSGM
Biosig Technologies Inc
Cash from Financing Activities
Biosig Technologies Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biosig Technologies Inc
NASDAQ:BSGM
|
Cash from Financing Activities
$17.3m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
5%
|
CAGR 10-Years
24%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Biosig Technologies Inc's Cash from Financing Activities?
Cash from Financing Activities
17.3m
USD
Based on the financial report for Dec 31, 2023, Biosig Technologies Inc's Cash from Financing Activities amounts to 17.3m USD.
What is Biosig Technologies Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
24%
Over the last year, the Cash from Financing Activities growth was 64%. The average annual Cash from Financing Activities growth rates for Biosig Technologies Inc have been -26% over the past three years , 5% over the past five years , and 24% over the past ten years .